Oxford Immunotec Schedules Third Quarter 2019 Earnings Release and Conference Call for November 5, 2019
October 22 2019 - 9:15AM
Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a
global, high-growth diagnostics company, today announced that it
plans to release third quarter 2019 financial results before the
open of the market on Tuesday, November 5, 2019. Dr. Peter
Wrighton-Smith, Chief Executive Officer, and Matt McLaughlin, Chief
Financial Officer, will host a conference call to review the
Company's financial results at 8:00 a.m. Eastern Time the same day.
The call will be concurrently webcast.
To listen to the conference call on your telephone, please dial
(855) 363-5047 for United States callers or +1 (484) 365-2897 for
international callers and reference confirmation code 7098484,
approximately ten minutes prior to start time. To access the live
audio webcast or subsequent archived recording, visit the Investor
Relations section of Oxford Immunotec's website at
www.oxfordimmunotec.com. The replay will be available on the
Company's website for approximately 60 days.
About Oxford Immunotec
Oxford Immunotec Global PLC is a global, high-growth diagnostics
company focused on developing and commercializing proprietary
assays for immunology and infectious disease. The Company's
T-SPOT®.TB test has been approved for sale in over 50 countries,
including the United States, where it has received pre-market
approval from the Food and Drug Administration, Europe, where it
has obtained a CE mark, as well as Japan and China. The Company is
headquartered near Oxford, U.K. and in Marlborough, MA. Additional
information can be found at www.oxfordimmunotec.com.
T-SPOT and the Oxford Immunotec logo are trademarks of Oxford
Immunotec Ltd.
CONTACTS:
For Media and Investor Inquiries: Matt
McLaughlinChief Financial OfficerOxford ImmunotecTel: +1 (508)
573-9953mtmclaughlin@oxfordimmunotec.com
Oxford Immunotec Global (NASDAQ:OXFD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Oxford Immunotec Global (NASDAQ:OXFD)
Historical Stock Chart
From Sep 2023 to Sep 2024